United States, 26th Mar 2025 – AmeraCell, a pioneering regenerative medicine company, is proud to announce a groundbreaking new treatment that harnesses the synergistic power of Nicotinamide Adenine Dinucleotide (NAD+) and Mesenchymal Stem Cells (MSC) to promote cellular health and combat inflammation.
This innovative therapy, available exclusively at AmeraCell, leverages the unique properties of NAD+ and MSC to restore cellular balance, enhance energy metabolism, and mitigate the effects of chronic inflammation.
“NAD+ and MSC are two of the most promising tools in the fight against aging and disease,” said AJ Pakpour, Founder and CEO of AmeraCell. “By combining these two powerful agents, we’ve created a revolutionary treatment that has the potential to transform the lives of millions.”
NAD+, a coenzyme essential for energy production and DNA repair, has been shown to decline with age, contributing to various diseases. MSC, a type of stem cell, possess anti-inflammatory and regenerative properties, making them an attractive therapeutic agent.
The treatment, which involves a proprietary blend of NAD+ and MSC, is administered via a minimally invasive procedure. Patients can expect to experience improved energy levels, enhanced cognitive function, and reduced inflammation.
“AmeraCell’s commitment to innovation and patient care has led to the development of this game-changing treatment,” added AJ Pakpour. “We’re excited to bring this breakthrough therapy to those seeking to optimize their health and well-being.”
To learn more about AmeraCell’s NAD+ and MSC treatment, please visit (link unavailable).
About AmeraCell
AmeraCell is a leading regenerative medicine company dedicated to developing innovative therapies that promote cellular health and combat disease. With a focus on NAD+ and MSC, AmeraCell is at the forefront of the rapidly evolving field of regenerative medicine.
Media Contact
Organization: AmeraCell
Contact Person: AJ Pakpour
Website: https://ameracell.com/
Email: Send Email
Country:United States
Release id:25774
View source version on King Newswire:
AmeraCell Revolutionizes Cellular Health with Breakthrough Treatment Combining NAD+ and MSC
It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No journalist was involved in the writing and production of this article.